CONTEXT Simulation-based medical education (SBME) is now ubiquitous at all levels of medical training. Given the substantial resources needed for SBME, economic evaluation of simulation-based programmes or curricula is required to demonstrate whether improvement in trainee performance (knowledge, skills and attitudes) and health outcomes justifies the cost of investment. Current literature evaluating SBME fails to provide consistent and interpretable information on the relative costs and benefits of alternatives.
CONTENT Economic evaluation is widely applied in health care, but is relatively scarce in medical education. Therefore, in this paper, using a focus on SBME, we define economic evaluation, describe the key components, and discuss the challenges associated with conducting an economic evaluation of medical education interventions. As a way forward to the rigorous and state of the art application of economic evaluation in medical education, we outline the steps to gather the necessary information to conduct an economic evaluation of simulation-based education programmes and curricula, and describe the main approaches to conducting an economic evaluation.
CONCLUSION A properly conducted economic evaluation can help stakeholders (i.e., programme directors, policy makers and curriculum designers) to determine the optimal use of resources in selecting the modality or method of assessment in simulation. It also helps inform broader decision making about allocation of scarce resources within an educational programme, as well as between education and clinical care. Economic evaluation in medical education research is still in its infancy, and there is significant potential for state-of-theart application of these methods in this area.
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INTRODUCTION
Over the past few decades, simulation has been integrated into the fabric of medical education across specialties and professions. Technologyenhanced simulation has been shown to improve the domain-specific knowledge, skills and behaviours of health care providers. [1] [2] [3] [4] Although simulation-based medical education (SBME) is effective, the establishment and maintenance of a programme is incredibly resource intensive. 5 Substantial resources have been reported for the construction (472 000 USD in 2005) and operation (67 875 USD in 2005) of an on-site 436-sq-ft simulation center (with only two laboratories), not including costs for human resources. 6 It remains unclear whether these costs actually yield greater performance or patient outcomes compared with other educational strategies or whether these resources should be allocated to clinical care instead of education.
It is generally believed that investing in medical education will benefit society by improving the quality of delivery of health care. Careful evaluation of both the effectiveness and the resource implications of SBME should be performed, given the substantial additional cost of simulation-based training. High-fidelity simulation may not always be superior to low-fidelity simulation. [7] [8] [9] There is evidence showing that low-cost models may yield learning outcomes similar to high-fidelity simulators. 10 Different modalities of simulation can be used to achieve the same learning objectives and assess the trainees (i.e., standardised patient versus manikin-based simulation in trauma management). 11 Additional evidence on the relative costs and outcomes for various types of SBME (i.e., modality of simulation and method of assessment) is required to inform adoption decisions. Economic evaluation of SBME curricula would help decision makers determine how to maximise educational value. 12, 13 In addition, economic evaluations can also play an important role in resolving the financial conflict between education and clinical care by helping policymakers make decisions about allocating resources between educational programmes and other areas of investment within the health care system. 12, 13 Methods of economic evaluation assessing health care programmes and interventions are already well established. [12] [13] [14] [15] Unfortunately, there is a scarcity of economic evaluation studies reported in the medical education literature. A systematic review reported that few simulation-based studies have reported the cost of simulation training compared with other instructional approaches. 16 The purpose of this paper is to define what constitutes an economic evaluation, describe the key components within the context of SBME and provide relevant examples for interpreting the results of economic evaluation. We also present the challenges of estimating costs and defining the outcome measures to assess the value of SBME, followed by some approaches for economic evaluation with examples.
DEFINING ECONOMIC EVALUATION
Economic evaluation is defined as the comparison of alternative options in terms of their costs and consequences (i.e., effect or outcome). 13 It is important because health care system resources (e.g., people, time, facilities, equipment and knowledge) are scarce. These identical issues apply in the evaluation of medical education programmes as well. Decision makers need to consider spending the least amount of resources to achieve a certain effect (technical efficiency), as well as how to efficiently allocate limited resources to achieve maximum effect (allocative efficiency). Every adopted intervention uses resources that could be utilised for other alternatives. The real cost of an intervention is not the number of dollars listed in a budget, but the forgone benefits that could have been achieved by other alternatives, that is the opportunity cost. The purpose of an economic evaluation is to estimate the opportunity costs and compare them with the benefits of alternatives. For example, if thinking about how best to allocate resources within a simulation programme, a decision made to allocate resources to develop a new simulation-based paediatric residency training curriculum would mean the programme director would be giving up other alternatives that would also benefit the programme (e.g., purchasing a state-of-the-art paediatric manikin). The opportunity cost of the new curriculum is the benefit of the manikin to the programme. Similarly, from a health care system perspective, the policymaker also gleans information from economic evaluation to support the decision to allocate resources (or not) to medical education, as the opportunity cost of an education programme is the benefit foregone of allocating those resources to clinical care instead.
It is important to note that not all studies that measure costs constitute an economic evaluation. An economic evaluation must examine both costs and consequences of at least two alternatives. 13 As an example, Trogdon et al. reported an economic evaluation where the effectiveness and costs of a continuing medical education (CME) programme for improving patient hypertension outcomes were compared with usual care. 17 Sometimes studies are carried out that contain only some elements of a full economic evaluation, and thus can be considered partial economic evaluations. When a comparison is absent (i.e., only one alternative is evaluated), the study is a description rather than an evaluation. If costs are evaluated solely, the study is a cost description. 13 For example, a study examining the costs of construction and operation of a simulation laboratory reported by Weinstock et al. 6 falls into this category. When both costs and outcomes are evaluated for the programme but without a comparison, the study is a cost-outcome description. 13 An example would be to examine the costs of developing and implementing a new training curriculum and the learning outcomes without comparison with current training curriculum. A study reporting only costs of two educational interventions without presenting outcomes is a cost analysis. 13 For example, one study compared the costs of a simulation-based curriculum versus conventional lectures for management of adverse reaction to iodinated contrast media in radiology residents. 18 The costs were compared between curricula, but the study did not examine the learning outcome of trainees (see Table 1 ).
Interpreting the results of economic evaluation
The interpretation of the results of economic evaluation relies on both incremental costs and incremental health and educational outcomes. If an intervention is found to be more effective than the comparator and also less costly (Fig. 1 , Quadrant IV), the intervention dominates the comparator and we can recommend adoption. There is also the analogous situation where the intervention is dominated and we can recommend against adoption (Fig. 1 , Quadrant II). Generally speaking, new programmes are more costly and also more effective than the status quo (Fig. 1, Quadrant I ). In these situations, a clear recommendation is not immediate but the economic evaluation provides explicit information on the trade-offs between alternatives. The explicit trade-off can be described by the amount of cost per increased unit of effectiveness according to an incremental cost-effectiveness ratio (ICER) 13, 15 :
The decision about whether to adopt is now driven by opportunity cost. Decision makers must assess whether this programme represents the best outcome gain for the extra resource investment relative to other programmes competing for implementation (Table 2) .
To illustrate this, consider the Trogdon et al. study, which conducted an economic evaluation to assess a CME programme for improving patient hypertension outcomes relative to usual care. 17 The CME intervention resulted in an additional 0.003 life years gain (LYG) and an additional $103 compared with usual care for each patient, and it cost an extra $39 494 for each LYG (ICER = $39 494/LYG; the calculation is not entirely accurate, probably as a result of rounding). In this case, the CME intervention is both more effective and more costly. Decision makers need to assess whether there is an alternative programme that could be implemented instead with a much lower ICER. If yes, the CME programme should not be adopted as its opportunity cost is too high. By contrast, if the CME intervention represents the lowest ICER compared with other possible interventions that could be implemented, then it should be adopted. Presenting the ICER allows the readers to decide if they will adopt the alternative in their own setting, by comparison with locally relevant opportunity cost information.
Incremental analysis is a critical feature of a properly conducted economic evaluation. For each of the alternatives, mean values for the main categories of estimated costs and outcomes, as well as the mean difference between the comparator groups, should be reported. 15 Depending on the results of the study as noted above, the incremental differences should be expressed as an ICER. Previous studies in medical education 19 and simulation 20 have reported costeffectiveness as an average cost per unit of effectiveness. However, expressing results in averages rather than incremental costs per unit of effect is incorrect and misleading. 15 For instance, using a published simulation-based study as an example, Iglesia-Vazques et al. compared the effectiveness and cost of high-fidelity simulation (HFS) versus low-fidelity simulation (LFS) in advanced life support (ALS) training. 20 The proportion of learners passing the ALS course in the HFS group was significantly higher than that in the LFS group (110/125, 88% versus 98/125, 78%; p < 0.01). HFS was superior to LFS if judging from effectiveness only. The total cost of teaching 125 learners was estimated to be €35 445 for LFS and €145 170 for HFS. The authors calculated the average cost per passing student in both groups (HFS = €1320 versus LFS = €392 per passing student; p < 0.001), and concluded that using LFS in ALS training is cost-effective. Because €1320 per student might not look extremely expensive and the HFS is more effective, educators might still consider high-fidelity simulation in their situation. However, if we look at these data from an incremental perspective, we might come to a different conclusion. Based on the data above, we can calculate: ICER = (€145 170 -€35 445)/(110 -98) passing student = €8893.75 per extra passing student. That means, if we implemented HFS instead of LFS, it would cost an additional €8893.75 per extra student passing the ALS training. These results provide a different perspective on cost that might influence the decision on whether to use HFS or LFS, and illustrate the importance of expressing data in incremental terms.
Other critical elements of economic evaluation
There are several important elements of rigorous application of economic evaluation that are beyond the scope of this paper. We summarise them below and refer interested readers to existing guidelines [13] [14] [15] for economic evaluation for more details.
1 Economic evaluation studies should describe the perspective of the study and the costs and effects being evaluated. 2 Costs and consequences should be reported and justified according to the chosen perspective and specified time horizon. Studies should also report the data sources and methods for estimating both resource utilisation and unit costs in a disaggregated way and justify the allocation of any shared resources. For studies over 1 year, a description and justification of the discount rate used for costs and consequences should be reported. 3 Sensitivity analysis should be conducted to deal with uncertainty in both costs and consequences, and examine variability around the mean incremental costs and effects.
Main types of economic evaluation
There are three main types of economic evaluation: cost-effectiveness analysis, cost-utility analysis and cost-benefit analysis. 12, 13, 15 Cost-effectiveness analysis (CEA) is used in situations where a decision maker has a given budget, and is considering a limited range of options within a given field. This is the most commonly used economic evaluation in SBME because the outcome measure of a CEA is measured in a meaningful unit related to the objective of the programme (i.e., an educationally or clinically relevant measure). Cost-utility analysis (CUA) differs from CEA by introducing a health-related quality of life measure (utility) as the outcome measure (e.g., quality adjusted life year, QALY). The strength of CUA is that investigators can compare the allocation of resources across different clinical areas or compare benefits of allocating resources to education or clinical care, given the outcome is standardised. 13 (Although the strength of the QALY is that the outcome is standardised, there are both theoretical and practical issues that temper this. Theoretically, the QALY model requires some strict assumptions and in practice there are many ways to derive a QALY, thus care should be taken in comparing across studies.) However, this type of economic evaluation is often not relevant to SBME, as most of the time simulation research evaluates learning outcomes rather than patient outcomes. Cost-benefit analysis (CBA) requires consequences to be valued in monetary units and therefore enables the investigators to make a direct comparison of an alternative's incremental cost with its incremental consequences in commensurate units of measurement. 13 The choice of type of economic evaluation depends on the research question (Table 3) .
CHALLENGES OF CONDUCTING AN ECONOMIC EVALUATION IN SIMULATION-BASED EDUCATION
Conducting economic evaluation in SBME can be challenging in the evaluation of both costs and effects.
Estimation of Costs
The estimation of costs for simulation-based educational interventions can be complicated. Prior economic evaluations carried out in health care and education can provide guidance. Drummond et al. proposed the components of costs in health programmes (i.e., health sector, other non-health government sectors, patient and family, and productivity losses). 13 These would have analogous categories in terms of SBME, but the primary sector may be education rather than the health sector, depending on how SBME is funded. Levin et al. describe the application of economic evaluation in general education and suggest educational cost categories, including costs related to equipment and materials, personnel, facilities, supplies, learner's input and other inputs. 12 In practice, some of the cost components are missing or are not well explained in the published SBME literature. Zendajas et al. 16 reported in a systematic review that most simulation-based research examining the costs of educational interventions focused on equipment and material only (i.e., prices of simulators) while neglecting the other components. Below, we list some issues related to each cost component in SBME.
1 Equipment and material: SBME research may involve new technology still in a prototype form, where estimated costs in the research setting may not be representative of the true costs of Table 2 Interpretation of cost-effectiveness analyses results
Background:
A medical educational researcher is going to examine the costs and effects of a new training method relative to the current method.
The evaluation will identify the incremental costs and the incremental effectiveness of the new programme compared with the current programme.
The cost of the current programme: $10 000 for 10 students
The effect of current programme: 60% rate of competency after training (6/10)
The association between incremental costs and incremental effectiveness could be one of the following situations. Compared with the current programme, the new programme could be: the final device in actual practice. 21 Some equipment might be donated or shared with other programmes. In addition, the depreciation, durability and maintenance cost of the equipment must also be considered in cost estimation. Although the costs of equipment upgrade are usually included in the price of the product, if additional customisation is required, the costs of equipment modification should not be ignored. 2 Personnel: Costs include not only the dollars spent, but also other resources used such as unpaid volunteer time or faculty members' time, regardless of whether their time is protected for education or not. Costs associated with confederate and actor training 22 in simulation-based education are not usually mentioned. 23 To keep an educational programme running, simulation programmes need not only administration staff and instructors, but also a site champion to maintain interprofessional leadership, team management, evaluation of the programme and quality assurance of the training. 23 3 Facility: One facility could accommodate multiple programmes. Allocation of shared costs is a critical component of cost estimation in this area. 4 Learner's input: If the learner was paid to participate in the learning programme, a productivity loss (cost related to loss of working time as a result of taking the training) should be estimated depending on the perspective chosen for the analysis. 5 Other inputs: There may be costs associated with intellectual property, such as creating, validating, evaluating and refining a new scenario or a new curriculum. 23 However, one scenario created can potentially be used in multiple programmes, and as such those costs should be shared. to pay by health care system) and compared with the directly measured cost CEA = cost-effectiveness analysis; CUA = cost-utility analysis; CBA = cost-benefit analysis; SBME = simulation-based medical education; QALY = quality-adjusted life year.
The estimation of costs should include not only the cost of the intervention, but also a cost changed by the intervention. For example, the total costs of a central line insertion training programme in an ICU would include the cost of developing and implementing the programme, less the cost savings as a result of decreased nosocomial infection. Although methods of estimating complex costs exist that can be applied in both simulation-based and conventional medical education, 12, 13, 15 there is a lack of rigorous application of those methods in simulation-based research. The conduct of economic evaluation of alternative simulation interventions should involve collaboration between simulation researchers and health economists. We provide a hypothetical example of estimating incremental costs (Table S1 ) and offer a few tips for the simulation researcher to consider when embarking on such a collaboration.
1 A costing exercise as part of an economic evaluation requires detailed familiarity with the components of both the intervention and comparator. Investigators should include cost categories that were often missed in the previous literature 16 (i.e., shared cost, volunteer time and cost associated with familiarisation with new technology). 2 Prioritise the identification of components that differ between the comparators: Because we focus on incremental costs in economic evaluation, investigators need to identify the costs that vary between comparators. Cost components that have equal utilisation in both interventions may be ignored because they cancel each other out in calculation of incremental costs. However, if this is done, interpretation of and comments on the total cost of one intervention should be undertaken with caution, as some costs were not measured. 3 Measure unit costs: Using market prices for monetary value for some components (i.e., equipment, manikin, utility, etc.) might be reasonable if a competitive market is available. If a market price is not available (i.e., cost of developing a new curriculum or volunteer time), a proxy amount should be estimated based on the time spent. 4 Measure the utilisation of the resource identified: This is helpful in dealing with shared costs. If a manikin or facility was used in several educational programmes, investigators should evaluate the proportion of utilisation and depreciation allocated to the intervention studied.
Allocate cost values for the different components:
The estimation of cost values should consider both unit costs and utilisation of the resources. Shared costs and durability of the products should be addressed with caution based on the proportion allocated to the intervention.
Outcome measures
The outcome measure used in an SBME economic evaluation, of the CEA type, should ideally be a well-defined competency-based outcome (i.e., guideline-compliant CPR). The competency standard should be clearly stated to allow meaningful interpretation of cost-effectiveness analysis. However, many simulation-based studies do not have clearly defined competency-based outcomes to measure performance. Simulation research often relies on a performance assessment tool score to evaluate learning, performance and behaviour. For example, the clinical performance tool (CPT) can be used to measure team performance in advanced life support scenarios. 24 Knowing the cost of a unit increase in the CPT score with implementation of a new simulationbased life support curriculum has little value in decision making, because we don't know how an improvement in scores relates to the actual performance of health care providers or clinical outcomes of patients. In addition, obtaining reliable and valid assessment of a trainee's ability itself can be difficult and costly. The validity evidence of these assessment tools in simulation research is suboptimal. 25, 26 Cook et al. 27 described in a systematic review that very few simulation-based studies (3%) using assessment instruments as an outcome measure have presented all five sources of evidence for validity frameworks. 28 If the estimation of effectiveness is not valid or does not make sense clinically or educationally, it will make the results of economic evaluation invalid or the interpretation of the results difficult.
Most of the time investigators are only able to obtain measures of educational outcomes in SBME studies. For example, to evaluate the effectiveness of an educational intervention to improve debriefing skills, researchers can assess the debriefing performance of simulation instructors and learner performance using validated assessment tools. 29 However, linking these learning outcomes to patient-related outcomes and costs to a health care system can be incredibly difficult without prior research supporting these links. Measuring patient outcomes from educational interventions is complicated by numerous confounding factors from both health care providers (i.e., level of training) and patients (i.e., severity of disease and socioeconomic status). Besides, examining patient outcomes is time consuming and it is extremely difficult to attribute patient outcome to a single provider or a team. Therefore, it is not surprising that only 10.9% of simulation research reports the provider behaviour or patient outcome. 30 
MAIN APPROACHES FOR PERFORMING AN ECONOMIC EVALUATION IN SIMULATION RESEARCH
The single-study-based economic evaluation, a piggybacked approach, is an efficient method of conducting an economic evaluation. 13 Both costs and consequence data are collected alongside a simulation-based comparison study. An example would be a randomised trial designed to compare the effect of a new technology versus current practice on neonatal intubation. The primary objective of the study is to examine the effectiveness of the intervention, and cost-effectiveness of the intervention is a secondary outcome. In this case, the estimation of costs and effectiveness could be valid and accurate in a well-designed randomised trial with good internal validity. However, a well-designed randomised trial usually has strict inclusion criteria and careful follow-up. The results reflect the efficacy rather than effectiveness of the intervention, whereas effectiveness is what we want to examine in economic evaluation. Also, the sample size that is calculated for the primary outcome in a randomised trial might not be sufficient for economic evaluation. As mentioned above, most SBME studies examine learning outcomes only; thus, the endpoint of economic evaluation in this approach is analogous to an intermediate outcome in health care (i.e., blood pressure reduction).
Model-based economic evaluation synthesises cost and consequences data from various sources to conduct an analysis. 13, 14, 31 In this approach, investigators develop a model using costs and effectiveness information collected from previous literature instead of only conducting primary data collection such as a trial. For example, consider the costeffectiveness of implementing a new data-driven postresuscitation debriefing programme (i.e., all health care providers involved in a real resuscitation event receive debriefing with objective data related to resuscitation after the event). The costs of building a programme and consequences of the programme (i.e., improved survival rate) can be derived from different studies. Economic evaluations using modelling allow investigators to assess the consequences over a longer period of time (i.e., large observational studies with long follow-up time), whereas the follow-up time for a randomised trial is relatively short. Investigators can also choose data representing real-world data, or data collected from a setting similar to their own, to improve the generalisability. However, the estimation of costs and consequences could also be biased depending on the quality of studies used. Extensive probabilistic sensitivity analysis can reveal how robust the model results are to the uncertainty of the parameter inputs.
The hybrid economic evaluation is the combination of two approaches mentioned above. This approach is often preferred, as it allows investigators to take advantage of the merits of both. For example, we could conduct an economic evaluation to examine the effect of real-time feedback devices during CPR on survival of patients who suffered a cardiac arrest. As noted earlier, direct links between the educational intervention and patient outcome are not always easy to establish. In this case, investigators could consider combining a single-study-based economic evaluation and a model-based approach to extend to outcomes beyond the trial by linking multiple sources of evidence. 32 We can start with a randomised trial to evaluate the cost of real-time feedback devices and their effect on CPR quality, such as the CPRCARES study, 33 which showed that use of real-time feedback devices is effective in improving compliance with published guidelines on chest compression depth by 33%. If the CPRCARES study also collected data on costs related to real-time feedback (i.e., equipment, training, etc.), it would build the first ring of the evidence chain related to the economic question, and provide information on incremental costs of the intervention as well as the impact on improved chest compression depth.
However, this is an intermediate outcome only. We could then use a model-based approach to link the compression depth with patient survival. In a large observational study, Vadeboncoeur et al. demonstrated that deeper chest compression is associated with better patient survival (adjusted odds ratio, 1.29) after out-of-hospital cardiac arrest. 34 This observational study provides evidence that improved skill in CPR is associated with better patient outcome, while adjusting for other confounding factors related to the prognosis of cardiac arrest. Putting this all together, we can link the real-time feedback with patient outcomes and estimate the final outcome (incremental survival of cardiac arrest patients). Compared with a single study trying to link CPR feedback with patient survival, these two studies use stronger causal designs that provide a chain of evidence. 32 Although the link is indirect, and thus subject to some assumptions, it permits more defensible inferences than a poorly designed single study. 32 With this approach, investigators can extract best evidence from both a primary effectiveness study and previous literature.
CONCLUSION
The implementation of SBME has rapidly increased over the past two decades. Stand-alone studies incorporating an economic evaluation in simulationbased education research are rare. Ultimately, these types of analyses will elucidate whether the potential gains in learning and health outcomes can justify the cost of SBME. Although some studies claimed to have examined the 'cost-effectiveness' of simulation-based educational intervention, none of them met the definition of a true economic evaluation. There is an important need for well-conducted economic evaluations in this area. Results of these studies will provide important evidence to inform the utility and sustainability of SBME. More importantly, they could start to address where, how best and when to use these educational interventions instead of the continued findings of 'some simulation training is better than no training'.
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